USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Applied Genetics, Inc.
City: Freeport
State: NY
Zip+4: 11520
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,377.00 6
SBIR Phase II $1,750,000.00 3

Award List:

A GROUP OF HUMAN TUMOR CELL STRAINS HAS BEEN IDENTIFIED THAT IS MORE SENSITIVE TO GROWTH INHIBITION PRODUCED BY HUMAN INTERFERON THAN ARE OTHER TUMOR CELL STRAINS OR NORMAL HUMAN FIBROBLASTS.

Award Year / Program / Phase: 1985 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel b. yarosh , PRINCIPAL INVESTIGATOR
Award Amount: $50,000.00
Abstract:
A group of human tumor cell strains has been identified that is more sensitive to growth inhibition produced by human interferon than are other tumor cell strains or normal human fibroblasts. this group of tumor strains, designated the mer-phenotype, shares a biochemical defect in dna repair. these… More

VERY HIGH RESOLUTION PSEUDO WELL LOGS OF VELOCITIES, PERCENTANISOTROPY, AND DENSITY FROM SEISMIC DATA

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: DOE
Principal Investigator: Dr W Daniel Heinze , Principal Investigator
Award Amount: $49,928.00
Abstract:
The travel times of coherent events in seismic surveys of the crust principally give information about the low spatialfrequency velocity field; details of the seismic signatures of backscattered events principally give information about the high spatial frequency of the velocity and density fields… More

MEASUREMENT OF O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE IN HUMAN TUMORS

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel B Yarosh
Award Amount: $50,000.00

UV-DNA REPAIR AND MUTAGENESIS IN LIPOSOME-TREATED CELLS

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel Yarosh
Award Amount: $49,449.00

UV-DNA REPAIR AND MUTAGENESIS IN LIPOSOME-TREATED CELLS

Award Year / Program / Phase: 1991 / SBIR / Phase II
Agency: HHS
Principal Investigator: Daniel Yarosh
Award Amount: $500,000.00
Abstract:
Skin cancer, resulting from ultraviolet (uv) light damage to dna, has increased dramatically in the united states and throughout the world. applied genetics, inc., has developed a method to enhance dna repair in human cells by treatment with liposomes containing uv-dna repair enzymes. phase i… More

MEASUREMENT OF O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE IN HUMAN TUMORS

Award Year / Program / Phase: 1992 / SBIR / Phase II
Agency: HHS
Principal Investigator: Daniel B Yarosh
Award Amount: $500,000.00
Abstract:
Nitrosoureas are effective antitumor agents, especially in brain cancer. however, tumors are often resistant due to activity of the human dna repair enzyme, o(6)-methylguanine-dna methyltransferase (o6mt). the outcome of chemotherapy may be predicted by measuring the levels of o6mt in single cells… More

ALKYLTRANSFERASE IN METASTATIC MALIGNANT MELANOMA

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Yarosh, daniel b
Award Amount: $100,000.00

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $0.00

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $750,000.00